C

Curis
D

CRIS

3.10000
USD
0.03
(0.98%)
Market Closed
Volume
2,789
EPS
-7
Div Yield
-
P/E
-0
Market Cap
26,247,567
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    6.675
    (2.79%)
    245.505 USD
    B
    BLUE
    -0.69000
    (-7.52%)
    8.49000 USD
    B
    BNTC
    -0.842
    (-6.85%)
    11.448 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    E
    EDIT
    -0.01000
    (-0.75%)
    1.32000 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    N
    NTLA
    0.120
    (0.99%)
    12.190 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    S
    SGMO
    0.17500
    (7.56%)
    2.49000 USD
    VRTX
    VRTX
    0.58
    (0.15%)
    397.15 USD
    More
News

Title: Curis

Sector: Healthcare
Industry: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advancedsolid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.